Increased odds of current asthma and wheeze seen at 4 to 6 years of age, but associations were null for outcomes at 8 to 9 years of age\n<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b>
\n<\/b><\/p>\n
THURSDAY, April 3, 2025 (HealthDay News) — Early-life ozone (O3<\/sub>) exposure is associated with asthma and wheeze outcomes at 4 to 6 years of age, according to a study published online April 2 in JAMA Network Open<\/em>.<\/p>\n Logan C. Dearborn, M.P.H., from the University of Washington in Seattle, and colleagues examined the associations between ambient O3<\/sub> and subsequent asthma and wheeze outcomes — independently and in mixture with fine particulate matter and nitrogen dioxide — in a pooled multisite analysis across six U.S. cities.<\/p>\n The analytic sample included 1,188 participants. The mean O3<\/sub> concentration was 26.1 parts per billion (ppb) in the first two years of life. The researchers found that 148 children had current asthma and 190 had current wheeze (12.3 and 15.8 percent, respectively) at age 4 to 6 years. Per 2 ppb higher O3<\/sub> concentration, the odds ratios were 1.31 and 1.30 for current asthma and current wheeze, respectively, at age 4 to 6 years; for outcomes at 8 to 9 years and for sensitivity covariate adjustment, the associations were null. Higher exposure to O3<\/sub> in mixture was associated with current asthma and wheeze in early childhood in Bayesian kernel machine regression.<\/p>\n “This analysis underscores the importance of better understanding the role of early-life exposure to ambient O3<\/sub> in addressing risk factors for pediatric asthma in the U.S.,” the authors write.<\/p>\n